Abstract
Exploiting an Asp-Glu “Switch” in Glycogen Synthase Kinase 3 to Design Paralog Selective Inhibitors for Acute Myeloid Leukemia Treatment
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have